Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?

European Heart Journal

Volumn 17, Issue 9, 1996, Pages 1362-1366

  Fatah, K ^a   Beving, H ^a   Albage, A ^a   Ivert, T ^a   Blomback, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acetylsalicylic acid; Cardiovascular disease; Fibrin gel network

Indexed keywords

ACETYLSALICYLIC ACID; FIBRIN;

ACETYLATION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLEEDING TIME; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; NORMAL HUMAN; PATIENT COMPLIANCE; PHYSICAL PHENOMENA; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; THROMBOCYTE; TREATMENT PLANNING;

EID: 0029844471     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a015070     Document Type: Article

References (0)